Your browser is no longer supported. Please, upgrade your browser.
QTRX [NASD]
Quanterix Corporation
Index- P/E- EPS (ttm)-1.17 Insider Own7.20% Shs Outstand30.14M Perf Week2.96%
Market Cap2.85B Forward P/E- EPS next Y-1.09 Insider Trans-5.56% Shs Float26.49M Perf Month25.15%
Income-32.70M PEG- EPS next Q-0.33 Inst Own75.80% Short Float1.88% Perf Quarter97.09%
Sales76.20M P/S37.40 EPS this Y-13.40% Inst Trans-1.04% Short Ratio1.24 Perf Half Y137.19%
Book/sh6.94 P/B11.91 EPS next Y5.20% ROA-17.00% Target Price72.00 Perf Year262.38%
Cash/sh- P/C- EPS next 5Y- ROE-23.00% 52W Range10.90 - 92.57 Perf YTD77.76%
Dividend- P/FCF- EPS past 5Y- ROI-30.40% 52W High-10.71% Beta-
Dividend %- Quick Ratio7.20 Sales past 5Y- Gross Margin52.50% 52W Low658.70% ATR7.02
Employees248 Current Ratio7.70 Sales Q/Q110.70% Oper. Margin-43.60% RSI (14)57.61 Volatility8.40% 8.61%
OptionableYes Debt/Eq0.04 EPS Q/Q118.90% Profit Margin-42.90% Rel Volume0.89 Prev Close75.75
ShortableYes LT Debt/Eq0.01 EarningsMar 02 AMC Payout- Avg Volume401.77K Price82.66
Recom- SMA204.65% SMA5026.22% SMA20095.12% Volume348,191 Change9.12%
Mar-01-21 10:05AM  
Feb-25-21 06:05PM  
Feb-23-21 11:19AM  
Feb-18-21 11:59AM  
Feb-12-21 02:08PM  
Feb-09-21 08:41AM  
Feb-08-21 03:12PM  
Feb-04-21 07:00AM  
Feb-03-21 04:25PM  
Jan-22-21 03:39PM  
Jan-13-21 08:30AM  
Jan-12-21 03:27AM  
Jan-11-21 06:03PM  
04:30PM  
Jan-06-21 04:06PM  
Dec-28-20 06:46PM  
Dec-10-20 12:02PM  
Dec-09-20 09:00AM  
Nov-18-20 04:28PM  
Nov-13-20 12:36PM  
Nov-09-20 07:29AM  
Nov-05-20 04:16PM  
Oct-30-20 05:32PM  
Oct-29-20 02:40PM  
Oct-28-20 11:37AM  
Oct-07-20 04:27PM  
Oct-06-20 03:32PM  
Oct-05-20 04:01PM  
Sep-10-20 09:00AM  
Aug-25-20 12:28PM  
Aug-11-20 04:34PM  
09:00AM  
Aug-06-20 10:12PM  
04:11PM  
Aug-04-20 04:29PM  
Aug-03-20 09:08AM  
Jul-29-20 09:30AM  
Jul-27-20 07:00AM  
Jul-20-20 10:41AM  
Jul-05-20 10:02PM  
Jun-26-20 09:37AM  
Jun-11-20 04:10PM  
May-29-20 12:37PM  
May-13-20 09:45AM  
May-11-20 09:14AM  
08:26AM  
May-06-20 10:02AM  
May-05-20 04:05PM  
May-01-20 11:00AM  
Apr-28-20 02:45PM  
Apr-24-20 06:04PM  
Apr-14-20 10:05AM  
Apr-10-20 04:00PM  
Apr-09-20 01:15PM  
Mar-27-20 09:45AM  
Mar-11-20 08:13AM  
Mar-09-20 04:05PM  
Feb-21-20 04:32PM  
Feb-11-20 11:44AM  
Jan-31-20 10:04AM  
Jan-10-20 02:03PM  
Dec-19-19 04:23PM  
Dec-11-19 10:27AM  
Nov-06-19 04:01PM  
Nov-04-19 04:00PM  
Nov-01-19 09:41AM  
Oct-25-19 09:13AM  
Oct-22-19 04:30PM  
Oct-18-19 11:13AM  
Oct-03-19 09:00AM  
Oct-01-19 09:46AM  
Sep-26-19 07:00AM  
Sep-24-19 01:14PM  
Sep-16-19 06:21PM  
Sep-11-19 08:00AM  
Aug-13-19 04:21PM  
Aug-09-19 07:45AM  
Aug-07-19 04:23PM  
08:25AM  
Aug-06-19 08:30AM  
Jul-31-19 09:00AM  
Jul-30-19 10:30AM  
Jul-26-19 11:16AM  
Jul-11-19 01:30PM  
Jun-28-19 12:15PM  
Jun-27-19 10:43AM  
Jun-26-19 04:00PM  
Jun-06-19 07:03AM  
Jun-04-19 04:00PM  
May-29-19 04:00PM  
May-16-19 10:30AM  
May-11-19 01:27PM  
May-10-19 11:23AM  
May-09-19 04:00PM  
May-06-19 11:30AM  
May-02-19 04:00PM  
Apr-01-19 07:14AM  
Mar-28-19 04:00PM  
Mar-18-19 05:48PM  
Mar-08-19 01:15AM  
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRUSOVSKY E KEVINChairman, President & CEOFeb 19Sale90.343,493315,5621,002,443Feb 22 04:34 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 19Sale90.3367060,52324,435Feb 23 04:43 PM
Chaubal AmolChief Financial OfficerFeb 19Sale90.3373366,21230,423Feb 23 04:45 PM
Mattoon DawnSr. VP, Research ProductsFeb 19Sale90.3387178,68033,642Feb 23 04:36 PM
Fry John JGeneral Counsel & SecretaryFeb 19Sale90.3387178,68034,530Feb 23 04:39 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 18Sale83.655,000418,2291,005,936Feb 22 04:34 PM
Duffy David C.SVP R&D and CTOFeb 11Sale79.621,667132,72739,952Feb 12 04:00 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 09Sale78.185,000390,8871,010,936Feb 10 04:11 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 01Sale68.261057,16721,732Feb 02 07:56 PM
Fry John JGeneral Counsel & SecretaryFeb 01Sale68.2616311,12631,722Feb 02 08:02 PM
Chaubal AmolChief Financial OfficerFeb 01Sale68.261339,07825,367Feb 02 08:04 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 01Sale66.778,249550,788997,539Feb 02 08:12 PM
Mattoon DawnSr. VP, Research ProductsFeb 01Sale68.2618212,42330,834Feb 02 09:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 25Sale77.815,000389,0561,005,788Jan 25 04:01 PM
Duffy David C.SVP R&D and CTOJan 22Sale79.291,667132,17639,473Jan 22 06:47 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 19Sale74.535,000372,6461,010,788Jan 21 07:55 PM
DEKKERS MARIJN EDirectorJan 11Option Exercise11.1044,962498,97854,042Jan 13 05:01 PM
DEKKERS MARIJN EDirectorJan 11Sale48.6544,9622,187,5149,080Jan 13 05:01 PM
Mattoon DawnSr. VP, Research ProductsJan 05Sale44.131707,50231,016Jan 06 04:21 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 05Sale44.13984,32521,837Jan 06 04:21 PM
Fry John JGeneral Counsel & SecretaryJan 05Sale44.131536,75231,885Jan 06 04:21 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 05Sale44.133,510154,9021,015,788Jan 06 04:21 PM
Chaubal AmolChief Financial OfficerJan 05Sale44.131245,47225,500Jan 06 04:23 PM
Duffy David C.SVP R&D and CTODec 18Option Exercise2.281,6303,71642,807Dec 21 05:03 PM
Duffy David C.SVP R&D and CTODec 18Sale43.821,66773,04841,140Dec 21 05:03 PM
HRUSOVSKY E KEVINChairman, President & CEODec 08Sale46.982,00093,9601,019,298Dec 10 05:48 PM
Roskey Mark T.SVP, Commercial & AcceleratorDec 01Sale43.75913,98121,935Dec 03 04:41 PM
Mattoon DawnSr. VP, Research ProductsDec 01Sale43.751586,91231,186Dec 03 04:40 PM
Chaubal AmolChief Financial OfficerDec 01Sale43.751155,03125,624Dec 03 04:40 PM
Fry John JGeneral Counsel & SecretaryDec 01Sale43.751416,16832,038Dec 03 04:40 PM
HRUSOVSKY E KEVINChairman, President & CEODec 01Sale43.753,236141,5691,021,298Dec 03 04:40 PM
HRUSOVSKY E KEVINChairman, President & CEONov 19Sale44.252,00088,5001,024,534Nov 20 04:19 PM
HRUSOVSKY E KEVINChairman, President & CEONov 12Sale49.392,00098,7801,026,534Nov 16 04:51 PM
Duffy David C.SVP R&D and CTONov 12Sale49.391,66782,33341,177Nov 16 04:51 PM
Madaus Martin DDirectorNov 05Option Exercise2.281,3723,12813,088Nov 06 04:01 PM
Madaus Martin DDirectorNov 05Sale42.451,37258,24111,716Nov 06 04:01 PM
Madaus Martin DDirectorNov 04Option Exercise2.281,6003,64813,316Nov 06 04:01 PM
Madaus Martin DDirectorNov 04Sale39.401,60063,04011,716Nov 06 04:01 PM
Chaubal AmolChief Financial OfficerNov 02Sale36.971164,28825,261Nov 03 04:04 PM
HRUSOVSKY E KEVINChairman, President & CEONov 02Sale36.973,264120,6661,028,534Nov 03 04:05 PM
Fry John JGeneral Counsel & SecretaryNov 02Sale36.971425,25031,085Nov 03 04:04 PM
Mattoon DawnSr. VP, Research ProductsNov 02Sale36.971595,87831,344Nov 03 04:09 PM
Roskey Mark T.SVP, Commercial & AcceleratorNov 02Sale36.97913,36421,188Nov 03 04:13 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 29Sale38.302,00076,6001,031,798Nov 03 04:05 PM
Madaus Martin DDirectorOct 20Option Exercise2.281,6003,64813,316Oct 20 04:24 PM
Madaus Martin DDirectorOct 20Sale42.571,60068,11211,716Oct 20 04:24 PM
Madaus Martin DDirectorOct 19Option Exercise2.281,6003,64813,316Oct 20 04:24 PM
Madaus Martin DDirectorOct 19Sale44.591,60071,34411,716Oct 20 04:24 PM
Duffy David C.SVP R&D and CTOOct 16Sale43.041,66771,74842,844Oct 20 04:15 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 13Sale44.492,00088,9801,033,798Oct 15 05:36 PM
Madaus Martin DDirectorOct 07Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 07Sale37.171,60059,47211,716Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Sale36.471,60058,35711,716Oct 08 05:43 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 05Sale33.902,00067,8001,035,798Oct 05 05:29 PM
Roskey Mark T.SVP, Commercial & AcceleratorOct 01Sale34.12923,13921,279Oct 02 04:00 PM
Chaubal AmolChief Financial OfficerOct 01Sale34.121163,95825,377Oct 02 04:00 PM
Mattoon DawnSr. VP, Research ProductsOct 01Sale34.121595,42531,503Oct 02 04:00 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 01Sale34.123,286112,1261,037,798Oct 02 04:00 PM
Fry John JGeneral Counsel & SecretaryOct 01Sale34.121434,88031,227Oct 02 04:00 PM
Madaus Martin DDirectorSep 29Option Exercise1.961,6003,13812,654Sep 30 04:10 PM
Madaus Martin DDirectorSep 29Sale32.521,60052,02511,196Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Option Exercise1.931,6003,08812,796Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Sale33.091,60052,94411,196Sep 30 04:10 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 24Sale32.262,00064,5201,041,084Sep 29 04:53 PM
Madaus Martin DDirectorSep 17Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Duffy David C.SVP R&D and CTOSep 17Sale32.431,66754,06144,511Sep 17 05:47 PM
Madaus Martin DDirectorSep 17Sale32.431,60051,88811,196Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Sale33.161,60053,05611,196Sep 17 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 15Sale33.153,500116,0371,043,084Sep 16 04:08 PM
Madaus Martin DDirectorSep 02Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 02Sale35.081,60056,12811,196Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Sale35.371,60056,59211,196Sep 03 07:44 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 01Sale34.913,390118,3491,046,584Sep 03 07:48 PM
Mattoon DawnSr. VP, Research ProductsSep 01Sale34.911655,76031,662Sep 03 07:50 PM
Fry John JGeneral Counsel & SecretarySep 01Sale34.911485,16731,370Sep 03 07:52 PM
Chaubal AmolChief Financial OfficerSep 01Sale34.911204,18925,493Sep 03 07:54 PM
Roskey Mark T.SVP, Commercial & AcceleratorSep 01Sale34.91953,31721,371Sep 03 07:56 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 25Sale35.283,500123,4681,049,974Aug 26 05:09 PM
Madaus Martin DDirectorAug 19Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Duffy David C.SVP R&D and CTOAug 19Sale34.921,68058,66646,178Aug 20 04:32 PM
Madaus Martin DDirectorAug 19Sale34.921,60055,87211,196Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Sale34.521,60055,23211,196Aug 20 04:32 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 14Sale36.723,500128,5331,053,474Aug 14 05:40 PM
DEKKERS MARIJN EDirectorAug 07Sale32.4927,619897,3410Aug 11 04:52 PM
Madaus Martin DDirectorAug 05Option Exercise1.933,2006,17614,396Aug 05 05:49 PM
Madaus Martin DDirectorAug 05Sale32.893,200105,24811,196Aug 05 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 04Sale32.114,000128,4371,056,974Aug 05 05:14 PM
Chaubal AmolChief Financial OfficerAug 03Sale32.261143,67725,613Aug 05 05:21 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 03Sale32.263,230104,1881,060,974Aug 05 05:14 PM
Fry John JGeneral Counsel & SecretaryAug 03Sale32.251414,54831,518Aug 05 05:10 PM
Roskey Mark T.SVP, Commercial & AcceleratorAug 03Sale32.25902,90321,466Aug 05 05:51 PM
Mattoon DawnSr. VP, Research ProductsAug 03Sale32.261565,03231,827Aug 05 05:53 PM
Madaus Martin DDirectorJul 21Option Exercise1.931,6003,08812,796Jul 22 07:13 PM
Madaus Martin DDirectorJul 21Sale31.451,60050,32011,196Jul 22 07:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJul 21Sale31.872,63684,0161,064,204Jul 23 08:38 PM
Madaus Martin DDirectorJul 20Option Exercise1.931,6003,08812,796Jul 22 07:13 PM